Thomas JS - Search Results

1

Metastatic clear cell renal cell carcinoma: A review of current therapies and novel immunotherapies.

Thomas JS, Kabbinavar F. Thomas JS, et al. Crit Rev Oncol Hematol. 2015 Dec;96(3):527-33. doi: 10.1016/j.critrevonc.2015.07.009. Epub 2015 Jul 20. Crit Rev Oncol Hematol. 2015. PMID: 26299335 Review.

2

Cutaneous Malignancies of the Head and Neck.

In GK, Thomas JS, Silk AW. In GK, et al. Among authors: thomas js. Hematol Oncol Clin North Am. 2021 Oct;35(5):991-1008. doi: 10.1016/j.hoc.2021.05.008. Epub 2021 Jul 16. Hematol Oncol Clin North Am. 2021. PMID: 34281755 Review.

3

Complete response with pembrolizumab in recurrent squamous cell carcinoma of the oral tongue: A case report.

Cheng JY, Hsu RC, Nieva JJ, Thomas JS. Cheng JY, et al. Among authors: thomas js. Oral Oncol. 2023 Dec;147:106597. doi: 10.1016/j.oraloncology.2023.106597. Epub 2023 Oct 17. Oral Oncol. 2023. PMID: 37857230

4

Assessing the predictive role of platelet-lymphocyte ratio in EGFR-mutated non-small cell lung cancer patients treated with tyrosine kinase inhibitors: an analysis across TKI generations.

Cooper R, Ramaswami D, Thomas JS, Nieva JJ, Hsu R. Cooper R, et al. Among authors: thomas js. Discov Oncol. 2024 Nov 21;15(1):689. doi: 10.1007/s12672-024-01606-9. Discov Oncol. 2024. PMID: 39570469 Free PMC article.

5

Complete response with talimogene laherparepvec in recurrent melanoma of the ear: A case report.

Hsu AC, Kokot NC, Eisenberg BL, Thomas JS. Hsu AC, et al. Among authors: thomas js. Oral Oncol. 2020 Dec;111:104899. doi: 10.1016/j.oraloncology.2020.104899. Epub 2020 Jul 11. Oral Oncol. 2020. PMID: 32665184

6

A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumors.

Thomas JS, El-Khoueiry AB, Maurer BJ, Groshen S, Pinski JK, Cobos E, Gandara DR, Lenz HJ, Kang MH, Reynolds CP, Newman EM. Thomas JS, et al. Cancer Chemother Pharmacol. 2021 Apr;87(4):525-532. doi: 10.1007/s00280-020-04224-8. Epub 2021 Jan 10. Cancer Chemother Pharmacol. 2021. PMID: 33423090 Free PMC article. Clinical Trial.

7

A Case Series of Multiple Primary Malignancies Among Patients With Advanced Melanoma.

Ebia MI, Capone S, Ricker C, Thomas JS, Tulpule V, Kang I, D'Souza A, Freyer DR, Miller K, In GK. Ebia MI, et al. Among authors: thomas js. Cureus. 2021 Jun 6;13(6):e15480. doi: 10.7759/cureus.15480. eCollection 2021 Jun. Cureus. 2021. PMID: 34262818 Free PMC article.

8

Characterization of Thyroid Cancer among Hispanics in California, USA, from 2010 to 2020.

Hsu RC, Tsai KY, Benjamin DJ, Chennapan K, Wojcik KY, Lee AW, Thomas JS, Nieva JJ, Liu L. Hsu RC, et al. Among authors: thomas js. Cancers (Basel). 2024 Mar 8;16(6):1101. doi: 10.3390/cancers16061101. Cancers (Basel). 2024. PMID: 38539437 Free PMC article.

9

CALR frameshift mutation detection in myeloproliferative neoplasms by microfluidic chip analysis.

Greenwood MP, Newton KM, Pepper KL, Hendrickson HL, Olsen RJ, Thomas JS. Greenwood MP, et al. Among authors: thomas js. Lab Med. 2024 Dec 24:lmae096. doi: 10.1093/labmed/lmae096. Online ahead of print. Lab Med. 2024. PMID: 39719677

10

From rounds to retweets: A digital media fellowship perspective.

Glatz C, Suileman M, Thomas JS, Tran P, Shah SS, Wray CM. Glatz C, et al. Among authors: thomas js. J Hosp Med. 2024 Nov 20. doi: 10.1002/jhm.13557. Online ahead of print. J Hosp Med. 2024. PMID: 39565009 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

292 results

Search Page

Filters